1. Home
  2. ADCT vs MVBF Comparison

ADCT vs MVBF Comparison

Compare ADCT & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • MVBF
  • Stock Information
  • Founded
  • ADCT 2011
  • MVBF 1997
  • Country
  • ADCT Switzerland
  • MVBF United States
  • Employees
  • ADCT N/A
  • MVBF N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • MVBF Major Banks
  • Sector
  • ADCT Health Care
  • MVBF Finance
  • Exchange
  • ADCT Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • ADCT 285.2M
  • MVBF 242.5M
  • IPO Year
  • ADCT 2020
  • MVBF N/A
  • Fundamental
  • Price
  • ADCT $1.98
  • MVBF $21.72
  • Analyst Decision
  • ADCT Strong Buy
  • MVBF Buy
  • Analyst Count
  • ADCT 5
  • MVBF 2
  • Target Price
  • ADCT $7.33
  • MVBF $27.00
  • AVG Volume (30 Days)
  • ADCT 417.8K
  • MVBF 28.1K
  • Earning Date
  • ADCT 11-07-2024
  • MVBF 10-30-2024
  • Dividend Yield
  • ADCT N/A
  • MVBF 3.12%
  • EPS Growth
  • ADCT N/A
  • MVBF N/A
  • EPS
  • ADCT N/A
  • MVBF 1.41
  • Revenue
  • ADCT $70,717,000.00
  • MVBF $140,251,000.00
  • Revenue This Year
  • ADCT $6.66
  • MVBF N/A
  • Revenue Next Year
  • ADCT $16.38
  • MVBF $7.01
  • P/E Ratio
  • ADCT N/A
  • MVBF $15.40
  • Revenue Growth
  • ADCT N/A
  • MVBF N/A
  • 52 Week Low
  • ADCT $0.69
  • MVBF $17.51
  • 52 Week High
  • ADCT $6.04
  • MVBF $25.24
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 25.90
  • MVBF 56.41
  • Support Level
  • ADCT $1.89
  • MVBF $20.70
  • Resistance Level
  • ADCT $3.06
  • MVBF $22.11
  • Average True Range (ATR)
  • ADCT 0.23
  • MVBF 0.83
  • MACD
  • ADCT -0.11
  • MVBF 0.01
  • Stochastic Oscillator
  • ADCT 8.83
  • MVBF 77.34

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.

Share on Social Networks: